Zhengye Biotechnology Holding Limited issued a statement on July 21, 2026, addressing unusual trading activity in its Class A ordinary shares. The Company confirmed it is not aware of any material non-public information that would account for the recent price and volume movements and stated that its business operations continue in the ordinary course. Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer focusing on livestock vaccines in China and overseas.